The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: September 2024

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development

  • 1. Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
  • 2. Characterization of the generic mutant p53-rescue compounds in a broad range of assays
  • 3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
  • 4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
  • 5. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
  • 6. Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
  • 7. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
  • 9. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
  • 10. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Previous
Next

Varveri, A. et al. Nature Communications. 15: 4988 (2024).
doi: 10.1038/s41467-024-49282-1.

Summary of the findings

Cancer-associated fibroblasts (CAFs) orchestrate an immunosuppressive tumour microenvironment (TME), significantly contributing to tumorigenesis and progression. In the article by Varveri et al, the authors identified α-SMA+ CAFs to be capable of processing and presenting tumour-associated antigens on T regulatory cells, through the formation of immunological synapses. These led to Treg cell activation and enhanced Treg-mediated immune suppression within the TME. Importantly, CAFs exhibited heightened autophagic activity which not only sustains them but also facilitated antigen-specific Treg activation. This process resulted in an amplified immunosuppressive milieu, promoting tumor immune evasion.
..
Immunological Synapse Formation Between T Regulatory Cells and Cancer-Associated Fibroblasts Promotes Tumour Development α-SMA+ CAFs in the tumour microenvironment form immune synapses with regulatory T cells (Tregs), facilitated by autophagy. This interaction enhances Treg activation and contributes to the immunosuppressive tumour microenvironment, promoting cancerous growth. Targeting autophagy in CAFs or disrupting the CAF-Treg immune synapse presents a promising strategy for enhancing the efficacy of immunotherapy, potentially reversing tumour immune evasion and improving patient outcomes. This figure was created with BioRender.com.

Future impact

This study demonstrates the role of CAF-derived autophagy in potentiating Treg activation, indicating that immune synapses formed between CAFs and Treg cells contribute significantly to the immunosuppressive environment within the TME. The results highlight the potential of targeting autophagy within CAFs as a therapeutic strategy to disrupt their ability to activate Tregs, thereby restoring immune surveillance and enhancing the response to immunotherapy. Thus, the clinical implications of the findings could represent a paradigm shift in cancer treatment, offering new strategies to overcome tumour resistance and improve patient outcomes.
.
Read more in Nature Communications

3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development

  • 1. Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
  • 2. Characterization of the generic mutant p53-rescue compounds in a broad range of assays
  • 3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
  • 4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
  • 5. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
  • 6. Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
  • 7. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
  • 9. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
  • 10. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

From Bedside to Bench: Lessons from three award-winning scientists – Episode 30 of The Cancer Researcher Podcast

From Bedside to Bench: Lessons from three award-winning scientists – Episode 30 of The Cancer Researcher Podcast

March 13, 2026

What happens when clinical care directly informs scientific discovery? This episode sees EACR award winners Charlie Swanton, Ayelet Erez and Daniel Kirschenbaum reflect on what drew...

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

January 16, 2026

Our guest in this episode is Bernhard Küster, Professor at the Technical University of Munich, Director of the Bavarian Biomolecular Mass Spectrometry Center and Co-Director of...

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

December 10, 2025

René Bernards (EACR Past President) and Johanna Joyce (EACR President Elect), together with Michael Baumann and Anton Berns, have written a new commentary highlighting the urgent...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

“Joint efforts can achieve far more than individual work”: Mariacristina Franzese Canonico’s EACR Travel Fellowship
Community

“Joint efforts can achieve far more than individual work”: Mariacristina Franzese Canonico’s EACR Travel Fellowship

April 1, 2026
“The ideal choice to advance my research”: Unai Heras Manterola’s EACR Travel Fellowship
Community

“The ideal choice to advance my research”: Unai Heras Manterola’s EACR Travel Fellowship

April 1, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR